Science ❯ Biology ❯ Immunology

Cancer Immunotherapy

T Cell Activation T Cell Receptor Therapy Monoclonal Antibodies TIL Therapy Cytokines Nanoparticles Immune Checkpoint Inhibitors Chimeric Antigen Receptor T-cells Vaccine Development

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

Researchers will use the findings to design a Phase II efficacy trial planned for late 2026.

Targeted Nanoparticles Help Checkpoint Drugs Erase Ovarian Tumors in Mice

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Nagoya University Advances Eva1-Targeted CAR-T Therapy to Preclinical Safety Testing